APL
Showing 26 - 50 of 331
Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- Realgar-Indigo naturalis formula
- +3 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan, Soliris)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
-
Los Angeles, California
- +52 more
Mar 1, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
-
Hong Kong, Hong Kong
- +6 more
Dec 14, 2020
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in United States (Pegcetacoplan)
Completed
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Los Angeles, California
- +6 more
Dec 14, 2020
Non-muscle Invasive Bladder Cancer Trial (APL-1202 treatment)
Completed
- Non-muscle Invasive Bladder Cancer
- APL-1202 treatment
- (no location specified)
Aug 12, 2020
Neovascular Age-related Macular Degeneration Trial in United States (Pegcetacoplan)
Terminated
- Neovascular Age-related Macular Degeneration
-
Beverly Hills, California
- +3 more
Sep 15, 2020
Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease Trial in United States (APL-2)
Active, not recruiting
- Warm Autoimmune Hemolytic Anemia
- Cold Agglutinin Disease
-
Whittier, California
- +7 more
Nov 20, 2020
Neovascular Age-Related Macular Degeneration Trial in Australia, United States (Pegcetacoplan)
Completed
- Neovascular Age-Related Macular Degeneration
-
Beverly Hills, California
- +3 more
Sep 11, 2020
HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)
Completed
- HIV Infections
- APL 400-047
- +2 more
-
Birmingham, Alabama
- +3 more
Oct 28, 2021
Non-Muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Myrtle Beach (APL-1202)
Completed
- Non-Muscle Invasive Bladder Cancer (NMIBC)
-
New York, New York
- +1 more
Jul 16, 2020
Pregnancy in Acute Promielocitic Leukaemia Patients Treated With
Recruiting
- Acute Promyelocytic Leukemia
- Pregnancy
-
Alessandria, Italy
- +36 more
Dec 31, 2021
Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)
Recruiting
- Acute Promyelocytic Leukemia
- Oral Arsenic Trioxide Formulation
-
Hong Kong, Hong KongThe University of Hong Kong
Dec 29, 2020
Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)
Active, not recruiting
- Geographic Atrophy
- APL-2
- Sham Procedure
-
Phoenix, Arizona
- +111 more
Jun 20, 2022
First CarpoMetacarpal Osteoartrithis, Basal Thumb Osteoartrithis Trial in Palma De Mallorca (Maïa® TMC Prosthesis (Lépine
Not yet recruiting
- First CarpoMetacarpal Osteoartrithis
- Basal Thumb Osteoartrithis
- Maïa® TMC Prosthesis (Lépine Groupe)
- APL Suspensionplasty
-
Palma De Mallorca, Islas Baleares, SpainHospital Son Espases
Sep 29, 2020
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (APL-2)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
-
Cali, Colombia
- +29 more
Oct 14, 2022
Arteriovenous Fistula Maturation in Hemodialysis or Without
Recruiting
- Chronic Kidney Diseases
- Data collection in medical records
- Blood sampling
-
Brussels, BelgiumBrugmann University Hospital
Oct 27, 2023
Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)
Active, not recruiting
- Geographic Atrophy
- APL-2
- Sham Procedure
-
Phoenix, Arizona
- +140 more
Jun 20, 2022
A Prospective, Multi-center, Observational Study for Signal-C
Not yet recruiting
- Colorectal Cancer
- Advanced Adenocarcinoma
- Signal-C™
- (no location specified)
Sep 26, 2023